Trials & Filings
Related Searches:
Filter by:
121 - 135 of 604 results
May 7, 2010
Bayer HealthCare Pharmaceuticals received approval from the FDA for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the prevention of pregnancy.
Read More »
May 7, 2010
Aeterna Zentaris Inc. has received orphan drug designation from the FDA for AEZS-108, a doxorubicin targeted conjugate compound for the treatment of ovarian cancer.
Read More »
May 3, 2010
AstraZeneca and Pozen, Inc. received approval from the FDA for Vimovo (naproxen and esomeprazole magnesium) delayed-release tablets for the relief of symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, and to decrease the risk of
Read More »
April 30, 2010
Dendreon Corp. received approval from the FDA for Provenge (sipuleucel-T), an autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic, castrate-resistant (hormone-refractory) prostate cancer (CRPC).
Read More »
April 23, 2010
Pfizer has discontinued the SUN 1170 Phase III study of Sutent (sunitinib malate) in advanced hepatocellular carcinoma (HCC), or liver cancer.
Read More »
April 23, 2010
Genentech, a wholly owned member of the Roche Group, has submitted a sBLA to the FDA for Herceptin (trastuzumab) plus chemotherapy in people with advanced, HER2-positive adenocarcinoma of the stomach, including gastroesophageal junction cancer.
Read More »
April 16, 2010
Alexion Pharmaceuticals, Inc. and Alexion Pharma International Sàrl received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for the use of Soliris (eculizumab) as a treatment for patients in Japan with paroxysmal nocturnal hemog
Read More »
April 14, 2010
Johnson & Johnson Pharmaceutical Research and Development (J&JPRD) received approval from the FDA for its NDA for Pancreaze (pancrelipase) delayed-release capsules for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or ot
Read More »
April 14, 2010
Baxter International and New York-Presbyterian Hospital/Weill Cornell Medical Center achieved positive results from an 18-month Phase II study of Gammagard Liquid and Gammagard S/D in mild-to-moderate Alzheimer’s disease.
Read More »
April 12, 2010
GE Healthcare achieved positive results from its multi-center Phase II study of flutemetamol, a positron emission tomography (PET) imaging agent for brain imaging.
Read More »
April 8, 2010
ADC drug expected to file in 1H11
Read More »
April 7, 2010
The FDA has approved Purdue Pharma's NDA for a reformulation of OxyContin (oxycodone HCl controlled-release) Tablets.
Read More »
April 6, 2010
Daiichi Sankyo has submitted a NDA to the Ministry of Health, Labor and Welfare in Japan seeking approval of edoxaban for the prevention of venous thromboembolism (VTE) after major orthopedic surgery.
Read More »
April 1, 2010
Obesity drug showed strong results in trials.
Read More »
121 - 135 of 604 results
